Adherence to National Cholesterol Education Program Treatment Goals in Postmenopausal Women With Heart Disease
- 23 April 1997
- journal article
- research article
- Published by American Medical Association (AMA)
- Vol. 277 (16) , 1281-1286
- https://doi.org/10.1001/jama.1997.03540400031027
Abstract
Objectives. —To determine the proportion of volunteer women with established heart disease who have low-density lipoprotein cholesterol (LDL-C) levels at or below the National Cholesterol Education Program Adult Treatment Panel goals and to determine what factors are associated with levels above goal or not receiving lipid-lowering medication when indicated. Design. —Cross-sectional measurement of lipids and lipoproteins, blood pressure, height, weight, and other demographic and cardiovascular risk factors in 2763 postmenopausal women with heart disease. Setting. —At 18 centers throughout the United States, participants were recruited by means of lists of women with coronary heart disease from coronary units and catheterization laboratories, direct mail to age-eligible women, and advertisements. Patients. —Mean age of the cohort was 66.7 years (range, 44-79 years) and the distribution by race/ethnicity was 88.7% white, 7.9% African American, 2.0% Hispanic/Latina, 0.8% Asian/Pacific Islander, and 0.7% other. Intervention. —We report cross-sectional analysis of the cohort at baseline. Outcome Measures. —We measured the frequency of achieving 1988 and 1993 Adult Treatment Panel treatment goals, and of being on a regimen of lipid-lowering medication. Results. —Although 47% of participants were taking a lipid-lowering medication, 63% did not meet the 1988 treatment goal of LDL-C level less than 3.4 mmol/L (130 mg/dL) and 91% did not meet the 1993 goal of LDL-C level less than 2.6 mmol/L (100 mg/dL). Factors independently associated with achieving the earlier goal were use of lipid-lowering medication, marital status, education, body mass index, exercise, hypertension, diabetes, gallbladder disease, and first diagnosis of coronary heart disease after 1990. Failure to use lipid-lowering medication was associated with age, being African American, marital status, body mass index, lack of exercise, alcohol consumption, current smoking, and first diagnosis of coronary heart disease before 1985. Conclusion. —The majority of women enrolled in the trial had LDL-C levels that significantly exceeded the treatment goals set by the 1988 and 1993 Adult Treatment Panel guidelines. Better implementation of these guidelines among women with coronary disease would be highlyd desirable.Keywords
This publication has 8 references indexed in Scilit:
- Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: A CASS registry studyJournal of the American College of Cardiology, 1995
- Is age an independent predictor of early and late mortality in patients with acute myocardial infarction?The American Journal of Medicine, 1992
- Age as a predictor of outcome: What role does it playThe American Journal of Medicine, 1992
- In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men.Circulation, 1991
- Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-upJAMA, 1990
- Acute myocardial infarction in women: Influence of gender on mortality and prognostic variablesThe American Journal of Cardiology, 1988
- Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham populationPublished by Elsevier ,1986
- Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry.Circulation, 1985